RecruitingNCT05199532

Eosinophilic Gastrointestinal Disorders Registry


Sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

Enrollment

500 participants

Start Date

Dec 18, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to learn more about Eosinophilic Gastrointestinal Disorders (EGIDs). With this registry we hope to find out more about the symptoms that patients have during their treatment, the quality of life they have with the diagnosis, what the disease looks like throughout the different treatment methods, and if there is a connection between EGIDs and connective tissue disorders. The goal of this study is to be able to better understand EGIDs and use information gained from all the information collected on this study for more precise treatments in the future. We want to create a large collection of samples, called a biorepository, to learn the most about EGIDs as possible. When the samples are collected, which will occur at procedures directed by your child's doctor as part of their standard of care, they will be stored for an unlimited amount of time to perform experiments on these samples and to gather information about EGIDs


Eligibility

Min Age: 1 YearMax Age: 25 Years

Inclusion Criteria2

  • Patients with an established diagnosis of an EGID, based on pathology findings from an endoscopy or colonoscopy with biopsies.
  • Patients suspected of having an EGID and undergoing endoscopic evaluation for further assessment

Exclusion Criteria1

  • Patients who do not consent to participate

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Ann & Robert H Lurie Children's Hospital of Chicago

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05199532


Related Trials